PM360

NOVEMBER 29, 2022

As healthcare marketers, we often focus on the official launch of a new product as a pinnacle moment for its commercial success. But in many cases, success depends on actions taken before the launch date—specifically, how well the market has been primed to receive a novel product.

Marketing 98

Marketing Healthcare Healthcare Education 98

Pharmaceutical Technology

OCTOBER 26, 2022

Bristol Myers Squibb (BMS) has reported a 3% decline in total revenues to $11.2bn in the third quarter (Q2) of 2022 as against $11.6bn in the year-ago quarter. The decline in Q3 revenue was driven by the latest LOE products, chiefly Revlimid, and impacts from foreign exchange. compared to $0.69 to $2.54-$2.84.

Medicine 59

Medicine Pharmaceutical Patients 59

Legacy MEDSearch

DECEMBER 7, 2022

Lazurite ranked as Commended for the Innovation, Product Launches and Research and Development categories. The company hit an important milestone in March 2022 when it received U.S. This was followed in September 2022 by another important step as the first surgery using the system was performed by orthopedic surgeon Laith M. “We

Networking 98

Networking Medical Food and Drug Administration Recruitment 98

European Pharmaceutical Review

NOVEMBER 30, 2023

The company stated that based on the IQVIA’s 2022 report: The impact of biosimilar competition in Europe , as of 2022 “the cumulative savings at list prices from the impact of biosimilar competition in Europe reached over €30 billion. Furthermore, since the launch of biosimilars these provided nearly 4.5

Marketing 99

Marketing Medicine Competition Distribution 99

European Pharmaceutical Review

JULY 7, 2022

The WuXi Biologics MFG14 facility has been performing Chemistry, Manufacturing and Controls (CMC) projects since early 2022, and has now started current good manufacturing practice (cGMP) manufacturing of microbial products. Around 1000 scientists work at the 35,000 square metre innovation centre. .

Manufacturing 85

Manufacturing Pharmaceutical Marketing Patients 85

European Pharmaceutical Review

OCTOBER 14, 2022

Amgen’s 2022 market report has detailed how competition has driven savings across healthcare, estimating that a considerable number of biologics will be in competition with biosimilars in five to 10 years. More interchangeable biosimilars are estimated to be approved and launched in the US in the next few years.

Competition 81

Competition Healthcare Healthcare Food and Drug Administration 81

Pharmaceutical Commerce

OCTOBER 5, 2022

Wednesday, October 5, 2022, 11am EDT Market access considerations can be complex to navigate and overwhelming to address for biopharmaceutical commercial teams launching their first specialty drug. Get answers to eleven key questions that will help guide commercial teams in effectively launching specialty products.

Marketing 52

Marketing 52

Pharmaceutical Technology

MARCH 28, 2023

In its FY 2022 report, BioNTech has identified herpes simplex virus (HSV), malaria, and shingles as disease targets. However, following its launch of the world’s first Omicron BA.4/BA.5 Covid-19 vaccine-related revenue is predicted to drop from an estimated $17.1bn in 2022 to $5bn in 2023.

Sales 110

Sales Safety Marketing 110

Impetus Digital

JANUARY 13, 2023

Product launches going virtual. The use of virtual and digital tools earlier in the product life cycle. In particular, AI-enabled sentiment analysis was a hot topic in 2022, but this will not replace manual analyses by medical writers and other human experts. We already saw a lot of focus on diversity in 2022.

Pharma 109

Pharma Medical Patients Healthcare 109

European Pharmaceutical Review

JANUARY 18, 2023

The expansion now includes off-patent products, bringing the total offering from 23 to around 500 products. We launched ‘ An Accord for a Healthier World’ [in May 2022] to help reduce the glaring health equity gap that exists in our world. billion people in 45 lower-income countries (LICs).

Medicine 82

Medicine Government Pharma Leads 82

European Pharmaceutical Review

AUGUST 21, 2023

According to Eli Lilly in early August 2023, its new products (select products launched since 2022: Jaypirca, Mounjaro and Omvoh) contributed $1.00 Revenue for Eli Lilly’s growth products (select products launched prior to 2022, including Jardiance, Retevmo, Taltz and Verzenio) increased 16 percent to $4.93

Biopharma 85

Biopharma Marketing Sales Medicine 85

European Pharmaceutical Review

AUGUST 4, 2023

billion in 2022, a product that was launched in 2002. Yet with the loss of exclusivity and the launch of Amgen’s Amjevita in January 2023, the first US adalimumab biosimilar, AbbVie reported a revenue decline of 26.1 There are at present, nine US Food and Drug Administration (FDA)-approved agents, GlobalData stated.

Marketing 82

Marketing Food and Drug Administration Food Medicine 82

European Pharmaceutical Review

JUNE 24, 2022

2022 is probably the biggest year in EU pharmaceutical law that I have seen in 30 years. 2022 is undeniably a critical year for change in the pharmaceutical industry: for the first time in several decades, the European Union (EU)’s pharmaceutical legislation is up for review. What are the implications of launching in all States?

Pharmaceutical 100

Pharmaceutical Medicine Marketing Competition 100

European Pharmaceutical Review

NOVEMBER 9, 2023

According to the BSI, all manufacturers of these products are eligible for the AMR certification to gain the BSI Kitemark , which involves an initial evaluation against the requirements of a designated international standard, published in June 2022.

Manufacturing 105

Manufacturing Pharmaceutical manufacturing Pharmaceutical Medicine 105

European Pharmaceutical Review

NOVEMBER 16, 2022

To ensure people in LMICs have access to new and innovative medicines and vaccines as soon as possible after launch, companies need to have an access plan in place for products in the pipeline from at least Phase II of R&D. Novartis signed the first licence for a non-communicable disease (NCD) product, a leukaemia medicine.

Medicine 86

Medicine Leads Pharma Manufacturing 86

PharmExec

OCTOBER 25, 2022

Wednesday, October 26, 2022 at 2pm EDT|11am PDT|7pm BST|8pm CEST In this webinar, we will we review case studies of successful thought leader engagement plans across the product launch continuum to address the complexity including establishing a modeling framework early, incorporating thought leader behavior profiles and peer recognition data in addition (..)

52

52

European Pharmaceutical Review

JANUARY 15, 2024

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Agamree ® (vamorolone), as a safer alternative to corticosteroids, for Duchenne muscular dystrophy (DMD). “In Initial European launch will be in Germany in Q1,” Dr Hasham confirmed.

Medicine 100

Medicine Safety Patients Pharmaceutical 100

Pharmaceutical Technology

NOVEMBER 25, 2022

In recent months, Wegovy (semaglutide), indicated for obesity, has been subjected to widespread supply shortages due to high demand, in addition to manufacturer production problems, with Novo Nordisk intending to relaunch Wegovy by the end of 2022.

Marketing 111

Marketing Patients Competition Manufacturing 111

European Pharmaceutical Review

JUNE 6, 2023

A new global Minimized Risk of Antimicrobial Resistance (AMR) certification has been launched to promote and demonstrate responsible antibiotic manufacturing in the global pharmaceutical supply chain. BSI, a UK standards body, developed the new certification to the Antibiotic Manufacturing Standard published in June 2022.

Manufacturing 95

Manufacturing Pharmaceutical manufacturing Pharmaceutical Pharma 95

PM360

OCTOBER 9, 2023

a pioneer in digital pharma marketing and patient acquisition solutions leveraging virtual care, today announced that the company has re-branded as Populus Health Technologies concurrent with the official launch of HCP Reach , its physician-facing virtual care channel. Populus Media Inc.,

Education 52

Education Consulting Media Healthcare 52

Eversana Intouch

JANUARY 20, 2022

“This is our opportunity to improve every sector of product commercialization.”. As we move into 2022 as a member of the EVERSANA family, we’re more than a little excited to see where our journey together takes us. When the space shuttle was in operation, it could launch a payload of 27,500 kilograms for $1.5

Pharma 52

Pharma Pharmaceutical products Consulting Management 52

European Pharmaceutical Review

FEBRUARY 1, 2023

billion in 2022 to $1.29 An increase in the number of drug launches and rising investment in R&D contributed to the growth of the market, found the Business Research Company, who produced the report. In the next five years, there will be a $196 billion increase in spending on new products. billion in 2023 at a CAGR of 8.9

Marketing 83

Marketing Pharmaceutical Manufacturing Pharma 83

PM360

NOVEMBER 12, 2023

Here’s the fact: since the pandemic, launch revenues in pharma have declined. The question is: What do you do to maximize the success of your launch? Importantly, digital spend in 2022 grew to over $1 billion, with a 45% increase from 2021 to 2022. It really does take a village to engender a successful drug launch.

Physicians 64

Physicians Marketing Sales Pharma 64

Pharmaceutical Technology

AUGUST 17, 2022

RANKINGS 2022 Excellence Innovation Commended Excellence Product Launch Commended Excellence Safety Commended. The company is ranked in the 2022 Excellence Rankings in the INNOVATION , PRODUCT LAUNCH and SAFETY categories. The Verdict. Northgate Technologies Inc.

Training 98

Training Safety Medical Media 98

European Pharmaceutical Review

OCTOBER 19, 2022

1 However, patent protection for pharmaceutical products is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment. Other inventions may include the drug product’s formulation and/or route of delivery. Internet] [link].

Food and Drug Administration 77

Food and Drug Administration Pharmaceutical products Pharmacology FDA 77

European Pharmaceutical Review

OCTOBER 4, 2023

The pharmaceutical firm originally announced the proposed departure from Novartis in August 2022. This would position the Ljubljana site as key location for its biosimilar product development, the company stated. To prepare for the separation, Sandoz stated in June that its headquarters would transfer to Basel, Switzerland.

CRM 94

CRM Medicine Competition Pharmaceutical 94

PM360

OCTOBER 3, 2023

In total, PM360 recognized 73 winners across eight overall categories: Companies of the Year, CEOs of the Year, Products of the Year, Marketer of the Year, Marketing Team of the Year, Lifetime Achievement, Brand Champions, and Initiatives. Yavornitzki, Senior Product Manager, U.S. Cardiology: Bradley A.

Education 122

Education Marketing Media Management 122

Pharma Leaders

MARCH 30, 2023

It also represents an opportunity for Navamedic to broaden its product portfolio and to support patients suffering from medical conditions, such as Parkinson’s. “We We are confident that the potential addition of Sensidose’s products will significantly strengthen our overall product offering and quickly become value generating upon launch.”

Distribution 52

Distribution Marketing Medicine Pharma 52

Pharmaceutical Technology

MAY 12, 2023

increase in its reported revenue to $29.96bn (Y4,027bn) during the fiscal year 2022 (FY2022) compared to that reported in FY2021. Our topline and profit performance was driven by our growth and launch products, which grew 19% at a constant exchange rate. Takeda has reported a 12.8% compared to the previous year.

Management 98

Management 98

Pharmaceutical Technology

DECEMBER 22, 2022

Below you can find all the winners from the 2022 Excellence Awards which celebrate the greatest achievements and innovations in the industry. However in 2022 it achieved two further groundbreaking approvals for recurrent or metastatic HER2-low breast cancer, and previously treated, HER2-mutant non-small cell lung cancer (NSCLC).

Medicine 52

Medicine Marketing Pharmaceutical Manufacturing 52

Pharmaceutical Technology

SEPTEMBER 23, 2022

Dry eye syndrome (DES) is an indication whose mainstay treatment has been dominated by Allergan’s Restasis (cyclosporine ophthalmic emulsion 0.05%) ever since its launch in 2003 in the US. Current treatment options for DES are dominated by a mix of prescription and over-the-counter (OTC) products.

Prescription 59

Prescription Physicians FDA Marketing 59

Pharmaceutical Technology

DECEMBER 19, 2022

This consists of any projects that have expanded the company’s footprint in the sector, including: contract wins; launching in new territories; launching new product lines; the acquisition and expansion of facilities and real estate; acquisition of new machinery or other assets; improved logistics; partnerships; and significant staff increases.

Marketing 52

Marketing Sales Strategy Manufacturing Pharmaceutical 52

pharmaphorum

JANUARY 4, 2023

It looks like Astellas has been unsuccessful in its attempt to block Pfizer’s generic medicines unit Hospira from launching a copycat version of big-selling pharmacologic stress agent Lexiscan in the US. The drug was originally developed by CV Therapeutics – bought by Gilead in 2009 – and first launched in the US in 2008.

Pharmacology 59

Pharmacology Pharma Marketing Competition 59

European Pharmaceutical Review

JANUARY 17, 2023

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted a marketing authorisation for Ximluci ® (ranibizumab), a biosimilar referencing Lucentis®, to help treat a leading cause of blindness globally. STADA is preparing to launch Ximluci ® in the UK during 2023. A biosimilar for biologic ophthalmic treatments.

Manufacturing 87

Manufacturing Medicine Marketing Safety 87

European Pharmaceutical Review

FEBRUARY 23, 2024

Richard Gonzalez will retire as the company’s CEO to become Executive Chairman, having served as the company’s CEO since its launch in 2013, AbbVie noted. Robert Michael will become AbbVie’s new CEO on 1 July 2024. AbbVie’s upcoming C-suite succession Robert has had “a tremendous impact” on AbbVie, according to Richard Gonzalez.

Marketing 81

Marketing Leads Medical Pharmaceutical 81

pharmaphorum

SEPTEMBER 26, 2022

Astellas has won a reprieve in its attempt to stop Pfizer’s generic medicines unit Hospira launching a copycat version of its pharmacologic stress agent Lexiscan in the US – but only for a couple of weeks. It was first launched in the US in 2008.

Pharmacology 52

Pharmacology FDA Pharma Marketing 52

European Pharmaceutical Review

JUNE 24, 2022

BioNTech has initiated construction of its first vaccine production facility in Africa. In a well-attended event that marked the launch of this monumental project, BioNTech welcomed its African partners and outlined its plans for the mRNA facility and for its malaria vaccine candidates.

Manufacturing 75

Manufacturing Training Networking Medicine 75